Bictegravir + Emtricitabine + Tenofovir Alafenamide

Fixed-dose combination

This page lists brands whose active-ingredient set is exactly the combination below. It is identity information only — a fixed-dose combination is not the same product as its single ingredients, and the brand names are not interchangeable across markets.

Not medical advice. Check the pack and the exact composition before comparing products; ask a pharmacist if unsure.

Active ingredients

Brands with this exact combination

BrandDoseManufacturer
bictegravir sodium, emtricitabine, and tenofovir alafenamide fumarateUS50 mg / 200 mg / 25 mg / 30 mg / 120 mg / 15 mgGilead Sciences, Inc.
Bictegravir 50mg / Emtricitabine 200mg / Tenofovir alafenamide 25mg tabletsAUGB50 mg / 200 mg / 25 mg / 30 mg / 120 mg / 15 mgGilead Sciences Ltd
emtricitabina + tenofovir alafenamida + bictegravirES200 mg / 25 mg / 50 mgGilead Sciences Ireland Unlimited Company
emtricitabine + tenofovir-alafenamide + bictegravirES200 mg / 25 mg / 50 mgGilead Sciences Ireland Unlimited Company
吉他韋 膜衣錠TW—香港商吉立亞醫藥有限公司台灣分公司
BIKTARVY bictegravir (as sodium) 50 mg, emtricitabine 200 mg, tenofovir alafenamide (as fumarate) 25 mg fixed-dose combination tablets bottleAU52.45 mg / 28.04 mg / 200 mgGilead Sciences Pty Ltd
BIKTARVY bictegravir (as sodium) 50 mg, emtricitabine 200 mg, tenofovir alafenamide (as fumarate) 25 mg fixed-dose combination tablets blister packAU52.45 mg / 28.04 mg / 200 mgGilead Sciences Pty Ltd

Same combination in other markets

These markets record products with the same active-ingredient combination. Identity only — not a recommendation that products are interchangeable.

See warnings for these ingredients

Source & licence: built from the same regulator data as the ingredient pages (openFDA, dm+d, CIMA, COFEPRIS, PBS/TGA, Health Canada DPD, NHSA). Facts only; see the licence register.